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DObjective: Our primary aim was to study postoperative complications in pediatric cardiac surgery patients and
their association with cardiopulmonary bypass (CPB) use. The secondary aim was to evaluate the association of
postoperative complications with established outcome measures.
Methods:A single-institution retrospective observational study was undertaken of consecutive pediatric cardiac
surgery patients during a 1-year period. Five cardiac and 15 extracardiac complications were studied. CPB use,
CPB parameters, demographics, and Risk Adjusted Classification for Congenital Heart Surgery (RACHS-1)
levels were evaluated as risk factors for complications. Outcomes, including mechanical ventilation duration,
pediatric cardiac intensive care unit stay, hospital stay, and mortality were studied.
Results:A total of 325 patients were studied: 271 with CPB and 54 without CPB. Of the 325 patients, 141 (43%)
had 1 complication (95% confidence interval, 38%-49%). Of the 325 patients, 82 (25%) developed cardiac
and 120 (37%) developed extracardiac complications. The evidence from logistic regression analysis was
insufficient to suggest a relationship between CPB support and the incidence of cardiac or extracardiac
complications after adjusting for age, gender, previous sternotomy, and RACHS-1 levels. For patients receiving
CPB, longer CPB times, higher RACHS-1 levels, and a lower temperature with CPB were associated with a
greater number of cardiac complications (P< .01). Longer CPB times and higher RACHS-1 levels were
associated with a greater number of extracardiac complications (P ¼ .006). Postoperative complications were
significantly associated with an increased mechanical ventilation duration, pediatric cardiac intensive care
unit stay, and hospital stay and mortality (P<.01).
Conclusions: Postoperative complications occurred in 43% of pediatric cardiac surgeries performed both with
and without CPB. The complications were associated with longer mechanical ventilation and pediatric cardiac
intensive care unit and hospital stays, and increased mortality. (J Thorac Cardiovasc Surg 2014;148:609-16)Supplemental material is available online.
National benchmark data have revealed that overallmortality
after congenital heart surgery is<4% at most institutions.1-3
The complications and the factors contributing to these
complications are more challenging targets to measure
and interinstitutional comparisons less easily made.
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The Journal of Thoracic and Capediatric cardiac surgery have been inconsistently reported
but contribute importantly to mortality, hospital stay, cost,
and quality of life after pediatric cardiac surgery.4-6
Focused on incentivizing cost-effective care, payers and reg-
ulators have also had an increasing interest in measuring
postoperative complications.7 The Centers for Medicare
and Medicaid Services have begun withholding payment
for certain complications, such as postoperative sternal
wound infections.7 Plans have been expanding to link pro-
vider remuneration to complication rates as theMedicare re-
visions have continued to unfold.
‘‘Failure to rescue’’ concepts have been applied to pediat-
ric cardiac surgery to demonstrate that institutions with the
best outcomes might not have fewer complications but,
rather, have the systems in place to recognize and correct
complications before deleterious outcomes ensue.5 Two pa-
tientswith the same technically excellent operation, delivered
to 2 different intensive care units, can have vastly different
courses and outcomes, depending on the recognition, preven-
tion, and treatment strategies for the same complications at
the respective institutions. The duration of mechanical venti-
lation, postoperative length of stay, and hospital stay can be
influenced by individual and institutional practices, compli-
cating interinstitutional comparisons.2,8,9 Optimal outcomesrdiovascular Surgery c Volume 148, Number 2 609
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
PCICU ¼ pediatric cardiac intensive care unit
RACHS-1 ¼ Risk Adjusted Classification for
Congenital Heart Surgery, version 1
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Ddepend on the contribution of multiple disciplines of care to
the journey of a patient from office to operating room to
intensive care unit to floor, and weaknesses in any of those
areas can subvert the successful work done in another. The
importance of improving the accurate recognition,
documentation, and standardization of accounting for
complications is relevant to the length of treatment, cost,
and clinical outcome. Few studies have reported an
association between complications and outcome measures
such as the duration of mechanical ventilation,
postoperative length of stay, and mortality.4,5 The primary
purpose of our study was to evaluate the cardiac and
extracardiac complications in the postoperative period and
to study the association of cardiopulmonary bypass (CPB)
use and the occurrence of these complications. Our
secondary purpose was to study the association of
complications with outcome measures such as the duration
of mechanical ventilation, postoperative length of PCICU
and hospital stay, and mortality.METHODS
The present retrospective study was conducted at the Pediatric Heart
Institute at Monroe Carell Jr Children’s Hospital at Vanderbilt University
and was approved by the Vanderbilt institutional review board. All pediat-
ric patients (age 0-18 years) who had undergone cardiac surgery during
2008 were included. Patients undergoing neonatal patent ductus arteriosus
ligation or reoperation during the same hospital admission and patients not
admitted to the PCICU for postoperative care were excluded from the pre-
sent study.
Postoperative complications were defined in accordance with the
consensus definitions of the Multi-Societal Database Committee for Pedi-
atric and Congenital Heart Disease (see Appendix Table E1). Complica-
tions were considered present if any 1 of the 20 predefined postoperative
complications occurred in the PCICU. They were categorized into 1 of
the 8 body systems: cardiac, neurologic, pulmonary, gastrointestinal, renal,
infectious, endocrine, and hematologic.10,11 Of the 20 complications, 5
were related to the cardiovascular system and 15 were related to the 7
extracardiac systems and evaluated for every patient studied. For much
of the statistical analysis, the complications were divided into cardiac
and extracardiac. Additionally, the length of mechanical ventilation,
PCICU stay, and hospital stay and mortality were evaluated. Mortality
was defined as death within the first 30 days after surgery or before
hospital discharge.3 We also evaluated the survival of these patients 1
year after their cardiac surgery.
The potential risk factors for an increased number of postoperative com-
plications in the present study included the use of CPB support, CPB time,
crossclamp time, lowest core temperature during CPB, lowest hematocrit
during CPB, total heparin dose, and post-CPB core body temperature.
The heparin dosage evaluated in our study corresponded to the heparin
administered to the patient during CPB (CPB prime and during CPB
period) and did not include any postoperative usage for patency of610 The Journal of Thoracic and Cardiovascular Surgindwelling catheters. Other potential risk factors evaluated included the
complexity of the cardiac surgery according to the Risk Adjusted Classifi-
cation for Congenital Heart Surgery, version 1 (RACHS-1),12 single- or
2-ventricle physiology, previous sternotomy, and demographics, including
age, weight, and gender.
The clinical data and outcomes were collected separately by a critical
care clinical nurse educator and a critical care physician from the electronic
medical records and patient charts. The data from both sources were
compared for any disparities. Any inclusion or exclusion of any complica-
tion was reviewed if disagreement was found between the 2 sources. The
data collection was also matched with the cardiac surgery division surgical
data, which had been collected separately.
Continuous variables are presented as median values and interquartile
ranges and categorical variables as numbers and percentages. For univari-
ate analysis, the Wilcoxon rank sum test was used to compare continuous
variables and Pearson’s chi-square test to compare categorical variables.
Proportional odds logistic regression analysis was undertaken to analyze
the risk factors for an increased number of cardiac and extracardiac com-
plications. Linear regression analysis was used to regress the length of me-
chanical ventilation and length of hospital stay on postoperative
complications, adjusting for relevant confounders. A log transformation
was used for the length of mechanical ventilation to satisfy normality as-
sumptions. Proportional odds logistic regression analysis and logistic
regression analysis were used to analyze the length of PCICU stay andmor-
tality with complications, respectively, adjusting for relevant confounders.
RESULTS
A total of 405 pediatric cardiac surgeries were performed
within 1 calendar year, and 325 patients met the inclusion
criteria for our study. Of the 80 excluded patients, 26 neo-
nates underwent patent ductus arteriosus ligation, 18 pa-
tients underwent reoperation during the same hospital
stay, and 16 patients were admitted directly to the cardiol-
ogy floor (10 patients underwent pacemaker placement or
revision, 2 patients underwent pericardial window creation,
3 patients underwent vascular ring resection, and 1 patient
underwent sternal wire removal).
The demographics and risk factors evaluated for 325 pa-
tients are listed in Table 1. Of the 325 surgeries, 271 (83%)
were performed with CPB support and 54 (17%) without
CPB support. Univariate analysis revealed that patients un-
dergoing surgery without CPB support were significantly
younger, weighed less, and had undergone fewer previous
surgeries compared with those undergoing surgery with
CPB support (Table 1). All 271 surgeries with CPB were
performed without the use of deep hypothermic circulatory
arrest.
Of the 325 patients studied, 141 (43%; 95% confidence
interval [CI], 38%-49%) experienced 1 complication. Of
the 271 patients who received CPB support, 126 (46%;
95% CI, 40%-53%) developed 1 complication. Of the
54 patients who underwent surgery without CPB support,
15 (28%; 95% CI, 16%-42%) had 1 postoperative
complication. The descriptive statistics for the 20 postoper-
ative complications evaluated in our study are listed in
Table 2, stratified by CPB support. Evaluation of the inter-
action between cardiac and extracardiac complications re-
vealed that all 37 renal complications, all 5 complicationsery c August 2014
TABLE 1. Demographics and risk factors of study population
Risk factor
CPB support
P valueYes (n ¼ 271) No (n ¼ 54)
Age (d) 202 (78-1194) 16.5 (8-139.7) <.001
Weight (kg) 6.8 (4.5-13.7) 3.4 (2.8-5.4) <.001
Gender
Male 152 (56) 32 (59) .88
Female 119 (44) 22 (41) .88
Previous surgery (yes) 95 (35) 4 (7) <.001
Ventricle physiology
Single 74 (27) 16 (30) .74
Two 197 (73) 38 (70) .74
RACHS-1 category
1 22 (8) 9 (17) .07
2 97 (36) 20 (37) .87
3 77 (29) 20 (37) .25
4 25 (9) 0 (0) .02
5-6 33 (12) 0 (0) .002
Unclassified 17 (6) 5 (9) .02
CPB time (min) 120 (88-158) NA —
Crossclamp time (min) 41 (24-58) NA —
Lowest temperature during
CPB (C)
29 (27.2-30.9) NA —
Lowest hematocrit during
CPB
31 (28-34) NA —
Heparin dose (U/kg) 414 (400-559) NA —
Post-CPB temperature (C) 35 (34-36) NA —
Data presented as median (interquartile range), with P value determined using
Wilcoxon rank sum test, or absolute number (%), with P value determined using
chi-square or Fisher’s exact test. CPB, Cardiopulmonary bypass; RACHS-1,
Risk Adjusted Classification for Congenital Heart Surgery, version 1; NA, not appli-
cable.
TABLE 2. Multiorgan postoperative complications
Complication
CPB support
Yes (n ¼ 271) No (n ¼ 54)
Cardiac, total 111 (40.9) 11 (20.3)
Cardiopulmonary resuscitation 16 (5.9) 4 (7.4)
Extracorporeal membrane oxygenation 18 (6.6) 1 (1.8)
Reoperation 14 (5.1) 4 (7.4)
Low cardiac output status 58 (21.4) 2 (3.7)
Permanent pacemaker 5 (1.8) 0 (0)
Extracardiac, total 169 (62.3) 14 (25.9)
Neurologic, total 13 (4.8) 2 (3.7)
Seizures/focal deficit 6 (2.2) 1 (1.8)
Abnormal neuroimaging findings 7 (2.6) 1 (1.8)
Respiratory, total 30 (11) 2 (3.7)
Use of inhaled nitric oxide 26 (9.5) 1 (1.8)
Paralyzed diaphragm 4 (1.5) 1 (1.8)
Gastrointestinal, total 5 (1.8) 1 (1.8)
NEC 4 (1.5) 1 (1.8)
Liver dysfunction 1 (0.4) 0 (0)
Renal, total 33 (12.2) 4 (7.4)
Acute renal failure (not requiring
replacement therapy)
13 (4.8) 2 (3.7)
Renal replacement therapy 8 (2.9) 0 (0)
Peritoneal dialysis catheter
placement
13 (4.8) 2 (3.7)
Infectious, total 23 (8.5) 4 (7.4)
Pneumonia 1 (0.4) 0 (0)
Sternal wound infection 6 (2.2) 1 (1.8)
Suspected sepsis/bacteremia 16 (5.9) 3 (5.5)
Endocrine, total 43 (15.8) 2 (3.7)
Hyperglycemia 38 (14) 1 (1.8)
Adrenal insufficiency 5 (1.8) 0 (0)
Hematologic 22 (8.1) 1 (1.8)
Bleeding requiring chest
re-exploration
22 (8.1) 1 (1.8)
Cardiac complications/patient
0 200 (73) 43 (80)
1 45 (17) 11 (20)
>1 26 (10) 0 (0)
Extracardiac complications/patient
0 163 (60) 42 (78)
1 72 (27) 11 (20)
>1 36 (13) 1 (2)
Total complications/patient
0 150 (55) 49 (91)
2 57 (21) 4 (7)
>2 64 (11) 1 (2)
Data presented as absolute number (%). CPB, Cardiopulmonary bypass.
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Dof adrenal insufficiency, 12 of 19 (63%) complications of
bacteremia/suspected sepsis, and 3 of 5 (60%) complica-
tions of necrotizing enterocolitis were associated with low
cardiac output. Eighteen patients underwent reoperation
during the period that included thrombosed shunts. These
18 patients had a greater number of cardiac and extracardiac
complications (4.68  2.45) than the patients who did not
require reoperation (2.06  1.53; P<.001).
The evidence from logistic regression analysis was insuf-
ficient to reveal differences in the incidence of cardiac or
extracardiac complications between cardiac surgeries per-
formed with and without CPB support after adjusting for
age, gender, previous sternotomy, and RACHS-1 level
(Table 3).
The point of occurrence of cardiac and extracardiac
complications in the postoperative pediatric cardiac sur-
gery patients who survived to hospital discharge is listed
in Table 4. Of the 80 cardiac complications and 131 ex-
tracardiac complications, 69 (86%) and 117 (89%)
occurred before extubation, respectively. The incidence
of permanent pacemaker implantation and gastrointestinal
and infectious complications was greater after extubation
(Table 4).The Journal of Thoracic and CaFor the 271 cardiac surgeries performed with CPB, the
results of the evaluation of risk factors for the number of car-
diac and extracardiac complications are listed in Table 5.
Proportional odds logistic regression analysis revealed that
a longer CPB time, higher RACHS-1 level, and lower tem-
perature during CPB were significantly associated with a
greater number of cardiac complications and that a longer
CPB time and higher RACHS-1 level were significantlyrdiovascular Surgery c Volume 148, Number 2 611
TABLE 3. Logistic regression analysis of complications and outcomes
Outcome
CPB support
OR 95% CI P value*Yes (n ¼ 271) No (n ¼ 54)
Cardiac complications 71 (26) 11 (20) 0.83 0.33-1.94 .626
Extracardiac complications 108 (40) 12 (22) 0.84 0.83-4.12 .135
CPB, Cardiopulmonary bypass; OR, odds ratio; CI, confidence interval. *Risk factors adjusted for logistic regression analysis included age, gender, previous surgery, and Risk
Adjusted Classification for Congenital Heart Surgery, version 1, category.
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Dassociated with a greater number of extracardiac complica-
tions. No cardiac complications occurred in those with
RACHS-1, category 1. Thus, to compare the risk of cardiac
complications across the RACHS-1 categories, applying
each category as an ordinate variable, RACHS-1 categories
3, 4, and 5-6were comparedwithRACHS-1 categories 1 and
2 together. For our analysis, only 1 multivariate logistic
regression model was fitted, in which the factors were
chosen a priori according to scientific and sample size
considerations. Any association presented in Table 5 for
a specific variable (eg, CPB time) and an outcome
(eg, cardiac complications) was thus adjusted for all other
factors listed.
The association of postoperative complications for CPB
patients with the length of mechanical ventilation and
PCICU stay is listed in Table 6. The presence of postoper-
ative complications, prolonged CPB duration, lower hemat-
ocrit and lower temperature during CPB, and younger age
were significantly associated with prolonged mechanical
ventilation. The presence of postoperative complications,TABLE 4. Point of occurrence of cardiac and extracardiac
postoperative complications and their relationship to extubation in
pediatric cardiac surgery patients surviving to hospital discharge
Complication n
Point of
occurrence (d)
Complications
occurring before
extubation
Cardiopulmonary
resuscitation
12 0 (0-12) 9 (75)
Extracorporeal membrane
oxygenation
5 0 (0-7.3) 5 (100)
Reoperation 12 10 (6.5-23.5) 9 (75)
Low cardiac output status 46 0 (0-0) 46 (100)
Permanent pacemaker 5 14 (14-15) 0 (0)
Neurologic, total 9 3 (2.5-6.5) 7 (78)
Use of inhaled nitric oxide 25 0 (0-0) 24 (96)
Paralyzed diaphragm 4 21 (12.7-33.5) 4 (100)
Gastrointestinal, total 4 21 (15-24) 1 (25)
Acute renal failure 7 5 (2-7) 6 (86)
Renal replacement therapy 2 3 (2.3-10) 2 (100)
Peritoneal dialysis catheter
placement
12 2 (1-7) 12 (100)
Infectious, total 23 12 (4.5-34.5) 16 (70)
Endocrine, total 29 0 (0-0) 29 (100)
Bleeding requiring chest
re-exploration
16 0 (0-0) 16 (100)
Data presented as median (interquartile range) or n (%).
612 The Journal of Thoracic and Cardiovascular Surghigher RACHS-1 level, and prolonged CPB duration were
significantly associated with a prolonged PCICU stay
(Table 6), after adjustment for relevant covariates.
The association of postoperative complications for CPB
patients with the length of hospital stay is listed in Table 7.
The presence of postoperative complications was signifi-
cantly associatedwith a prolonged hospital stay, after adjust-
ment for relevant covariates.
For the 54 surgeries performed without CPB support,
complications were significantly associated with prolonged
mechanical ventilation (45.42  27.21 hours vs 17.85 
18.16 hours; P ¼ .001), a prolonged PCICU stay (11.67
 12.26 days vs 3.17  4.38 days; P ¼ .002), and a pro-
longed hospital stay (24.6  31.56 days vs 7.56  8.43
days; P ¼ .004) compared with no complications.
Postoperative complications had developed in all 22 pa-
tients who died in our study. The patients who died had a
significantly greater number of complications (4.1  2.0)
than those who survived (0.7  1.2; P<.001). Evaluation
of the association of mortality with the individual complica-
tions revealed mortality in 12 of 19 patients (63%)
requiring extracorporeal membrane oxygenation support,
7 of 18 (39%) requiring reoperation, 7 of 20 (35%)
requiring cardiopulmonary resuscitation, and 15 of 60
(25%) with low cardiac output. Mortality was also observed
in 13 of 24 patients (54%) with acute renal failure with or
without the need for renal replacement therapy, 9 of 39
(23%) with hyperglycemia, and 5 of 27 (18%) with infec-
tious complications. Greater mortality was observed in
those with combined cardiac and extracardiac complica-
tions (18 of 59 patients [30.5%]) than those with either car-
diac or extracardiac complications (4 of 79 patients [5%];
P<.001).
For the 271 surgeries performed using CPB, logistic
regression analysis revealed that the RACHS-1 level was
associated with mortality (odds ratio, 1.73; 95% CI, 1.22-
2.66; P ¼ .013). Also, the total number of cardiac and ex-
tracardiac complications was significantly associated with
mortality (odds ratio, 2.10; 95% CI, 1.52-2.91; P<.001).
Likewise, for the 54 surgeries performed without CPB,
the presence of complications in 15 patients was signifi-
cantly associated with mortality compared with a lack of
complications in 39 patients (P ¼ .018).
The association of postoperative complications with sur-
vival persisted beyond the hospital stay. Of the 184 patients
without postoperative complications evaluated 1 year afterery c August 2014
TABLE 5. Evaluation of risk factors for patients undergoing cardiac surgery with cardiopulmonary bypass for cardiac and extracardiac
complications
Risk factors
Cardiac complications Extracardiac complications
OR (95% CI) P value OR (95% CI) P value
Age (y) 0.99 (0.85-1.16) .96 1.02 (0.93-1.13) .65
Gender (male vs female) 1.18 (0.51-2.73) .69 1.23 (0.65-2.34) .53
Previous surgery (yes vs no) 0.76 (0.14-4.16) .75 0.84 (0.28-3.18) .94
Single-ventricle physiology 0.81 (0.12-5.59) .83 0.95 (0.28-3.18) .12
RACHS-1 category .02* .03y
2 — 1.03 (0.19-5.65)
3 2.75 (0.81-9.36) 2.69 (0.45-15.95)
4 6.54 (1.78-24.04) 1.98 (0.28-13.89)
5-6 10.16 (1.11-93.24) 4.78 (0.51-44.36)
CPB time (h) 1.98 (1.13-3.46) .02 1.94 (1.21-3.12) .006
Crossclamp time (min) 0.99 (0.97-1.01) .40 0.99 (0.98-1.00) .33
Lowest temperature during
CPB (C)
0.79 (0.67-0.94) .007 0.95 (0.84-1.07) .38
Lowest hematocrit during
CPB
1.09 (0.99-1.21) .06 1.07 (0.98-1.15) .10
Heparin (U/kg) 0.99 (0.93-1.00) .27 0.99 (0.79-1.25) .21
Post-CPB temperature (C) 0.99 (0.93-1.07) .93 0.99 (0.98-1.00) .96
P value determined from proportional odds logistic regression model. OR, Odds ratio; CI, confidence interval; RACHS-1, Risk Adjusted Classification for Congenital Heart
Surgery, version 1; CPB, cardiopulmonary bypass. *P value determined by analyzing RACHS-1 levels as categorical variables comparing each category with RACHS-1 cate-
gories 1-2. yP value determined by analyzing RACHS-1 levels as categorical variables comparing each category with RACHS-1 category 1.
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Dcardiac surgery, data were missing for 32 patients (17%),
and none of the remaining 152 patients had died. Of the
141 patients with complications, 22 had died during their
hospital stay. Of the 119 patients with postoperative compli-
cations who were discharged home, data were missing for
21 patients (17%) and 4 patients had died within 1 year
of follow-up. The difference in the number of deathsTABLE 6. Study of cardiopulmonary bypass parameters and complications
stay
Risk factor
Mechanical ventila
Ratio of geometric mean (95%
Age (y) 0.99 (0.97-1.03)
Gender (male vs female) 1.02 (0.83-1.26)
Previous surgery (yes vs no) 0.82 (0.57-1.18)
Single-ventricle physiology 1.32 (0.88-1.97)
RACHS-1 category
2 1.18 (0.77-1.79)
3 1.75 (1.09-2.82)
4 2.39 (1.39-4.10)
5-6 2.00 (1.03-3.91)
CPB time (h) 1.11 (0.94-1.31)
Crossclamp time (min) 1.00 (0.99-1.01)
Lowest temperature during CPB (C) 0.97 (0.94-1.01)
Lowest hematocrit during CPB 1.01 (0.99-1.04)
Heparin (U/kg) 1.00 (0.99-1.00)
Post-CPB temperature (C) 1.00 (0.99-1.00)
Complications (yes vs no) 1.38 (1.10-1.74)
PCICU, Pediatric cardiac intensive care unit; CI, confidence interval; OR, odds ratio; RA
cardiopulmonary bypass. *P value determined using linear regression analysis. yP value d
according to RACHS-1 levels analyzed as categorical variables comparing each category
The Journal of Thoracic and Cabetween patients with and without complications was statis-
tically significant (P ¼ .028). Evaluation of the 98 patients
with postoperative complications who were discharged
home revealed that the 4 patients who subsequently died
had had significantly more postoperative complications
(3.8  2.8) than the 96 patients who survived (2.1 1.5;
P ¼ .036).with mechanical ventilation duration and pediatric intensive care unit
tion duration PCICU stay
CI) P value* OR (95% CI) P valuey
.84 0.99 (0.92-1.07) .86
.84 1.28 (0.75-2.2) .36
.3 0.49 (0.18-1.32) .16
.18 1.96 (0.68-6.6) .21
.24z .003z
1.98 (0.59-6.59)
4.37 (1.16-16.41)
12.47 (2.70-57.14)
6.94 (1.17-41.2)
.20 2.16 (1.41-3.32) <.001
.86 0.99 (0.98-1.01) .63
.13 0.94 (0.86-1.03) .19
.25 1.05 (0.98-1.11) .15
.48 1.00 (0.99-1.00) .91
.83 1.00 (0.99-1.00) .63
.006 2.51 (1.41-4.45) .002
CHS-1, Risk Adjusted Classification for Congenital Heart Surgery, version 1; CPB,
etermined using proportional odds logistic regression analysis. zP value determined
with RACHS-1 category 1.
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TABLE 7. Study of cardiopulmonary bypass parameters and
complications with length of hospital stay
Risk factor
Length of hospital stay
Ratio of geometric
mean (95% CI) P value*
Age (y) 0.99 (0.97-1.03) .20
Gender (male vs female) 1.02 (0.83-1.26) .84
Previous surgery (yes vs no) 0.77 (0.52-1.13) .18
Single-ventricle physiology 1.32 (0.88-1.97) .18
RACHS-1 category .24y
2 1.18 (0.77-1.79)
3 1.75 (1.09-2.82)
4 2.39 (1.39-4.11)
5-6 2.00 (1.03-3.91)
CPB time (h) 1.11 (0.94-1.31) .20
Crossclamp time (min) 1.00 (0.99-1.00) .86
Lowest temperature during CPB (C) 0.97 (0.94-1.01) .13
Lowest hematocrit during CPB 1.01 (0.99-1.04) .25
Heparin (U/kg) 1.00 (0.99-1.00) .48
Post-CPB temperature (C) 1.00 (0.99-1.00) .83
Complications (yes vs no) 1.38 (1.10-1.74) .006
CI, Confidence interval; RACHS-1, RACHS-1, Risk Adjusted Classification for
Congenital Heart Surgery, version 1; CPB, cardiopulmonary bypass. *P value deter-
mined using linear regression analysis. yP value determined according to RACHS-1
levels analyzed as categorical variables comparing each category with RACHS-1
category 1.
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DDISCUSSION
Our data have demonstrated that postoperative cardiac
and extracardiac complications occurred in 43% of pediat-
ric cardiac surgery patients. Postoperative complications
occurred in surgeries performed both with and without
CPB support. For those performed with CPB, a longer
CPB duration was significantly associated with an increased
number of cardiac and extracardiac complications. Postop-
erative complications were significantly associated with
other established outcome measures, including the duration
of mechanical ventilation, length of PCICU stay, length of
hospital stay, and mortality.
Our study revealed a greater incidence of extracardiac
complications compared with cardiac complications. The
complication rate we observed was greater than the previ-
ously reported rates of 33% to 39% in pediatric patients
and 29% in neonatal patients.4-6 The greater complication
rate observed in our study might have resulted from a
more inclusive method of data collection. We used simple
and unequivocal criteria to define each complication.10,11
Complications were derived from the clinical charts after
manually reviewing multiple data observations, including
physician notes, nurse records, radiologic and laboratory
results, and hemodynamic monitoring points. Previous
reports on the incidence of postoperative complications
have been assessed from administrative and clinical
databases.4-6 An administrative database study by
Benavidez and colleagues4 applied the ‘‘International614 The Journal of Thoracic and Cardiovascular SurgClassification of Diseases, 9th Revision, Clinical Modifica-
tion,’’ to define the complications and reported that one
third of pediatric cardiac surgery patients had complica-
tions. Administrative data provide limited clinical informa-
tion and have problems in coding accuracy, variation, and
limited insight into the timing and severity of events.13
Codes cannot reliably distinguish between comorbidities
and procedural complications.13 Administrative databases
have wide discrepancy with clinical databases in the report-
ing of cases, mortality, and diagnoses.14 Clinical databases,
although more accurate in anatomic and operative detail,
vary from institution to institution in the degree of capture
of complications.15,16 A clinical database study by
Pasquali and colleagues5 applied Society of Thoracic Sur-
geons Congenital Heart Surgery database definitions and re-
ported a complication rate of 39%. Comparisons of the
clinical data with the Society of Thoracic Surgeons Na-
tional Cardiac database have shown discrepancies of 6%
for composite major morbidity/mortality and 36% for
ventilation time.15 A comparison of the Society of Thoracic
Surgeons Congenital Heart Surgery database records with
clinical data revealed a lack of agreement of 40% for the
initial extubation date and time, 38% for 30-day mortality
status, and 29% for postoperative complications.16 The
discrepancy in complications resulted predominantly from
underreporting.16
We observed that postoperative complications occurred
in cardiac surgeries performed both with and without
CPB. Our observations differed from previous study results,
which reported an increase in postoperative complications
in pediatric cardiac surgery undertaken with CPB compared
with no CPB.6 The variance in observations between the 2
studies might have resulted from differences in the study
populations and the analysis undertaken. Kansy and col-
leagues6 studied neonatal cardiac surgery patients and re-
ported an increase in complications with CPB use from
the univariate analysis. Increased complexities of cardiac
defects, including RACHS-1 level category 5 and 6, which
are associated with a greater incidence of postoperative
complications, will be performed in the neonatal period.4
Our study population included all age groups (0-18 years),
with the exclusion of neonatal patent ductus arteriosus liga-
tion and surgical patients admitted directly to the pediatric
cardiology floor for postoperative care. Our analysis of the
number of complications was adjusted for multiple param-
eters, including age, gender, previous sternotomy, and
RACHS-1 level. For cardiac surgery performed with CPB,
our study observations revealed that an increased duration
of CPB and increased cardiac defect complexity were sig-
nificant risk factors for an increased number of cardiac
and extracardiac complications. These observations are
partly in agreement with those from previous studies.4,6
Additional support for an association of the CPB duration
with the occurrence of complications includes aery c August 2014
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diators and cytokines with the duration of CPB.17,18
Our study observations revealed that postoperative com-
plications after CPB use were significantly associated with
other measured outcomes, including the duration of me-
chanical ventilation, length of intensive care unit and hospi-
tal stay, and mortality, after adjustment for relevant
confounders. Our results are partly in agreement with those
from adult cardiac surgery studies that have reported that
postoperative complications were significantly associated
with a prolonged hospital stay.19,20 A general tendency
exists to optimize the patient’s vital parameters and ensure
multiorgan system stability before a pediatric cardiac
surgery patient is extubated and subsequently transferred
to the pediatric cardiology floor. Of the complications in
our study population, 86% of cardiac and 89% of
extracardiac complications occurred before extubation.
Thus, the presence of any postoperative complication
would delay extubation and transfer to the pediatric
cardiology floor. The association of postoperative
complications with worse outcomes in our study persisted
beyond the perioperative period, with a prolonged hospital
stay and decreased rate of survival 1 year after cardiac
surgery. The association of postoperative complications
with mortality is consistent with the findings of previous
studies.4,5
The present single-center retrospective study was limited
by the subjectivity of defining and counting the complica-
tions and the limited ability to generalize the findings mean-
ingfully to other institutions with different systems. Second,
we did not assess whether the postoperative complications
were a complication of a specific surgical intervention. Of
the 20 patients in our study who developed postoperative
acute renal failure, 2 had had preoperative renal dysfunc-
tion, and 8 of the 30 patients who had received inhaled nitric
oxide postoperatively had pre-existent elevated pulmonary
vascular resistance or elevated pulmonary artery pressure.
None of the patients who had developed neurologic compli-
cations were known to have had them before surgery, and
none of the patients who developed necrotizing enteroco-
litis had been premature. All the neonatal patients under-
went head and renal ultrasonography before surgery to
rule out major structural abnormalities. Third, because of
our study design was retrospective, human factors,
including surgical practices, difficulties during surgery, var-
iations in CPB techniques, and the management practices of
the different anesthesia and cardiac critical teams, could not
be evaluated. Fourth, we used the RACHS-1 level to eval-
uate the complexity of the cardiac defect. Better models
might be available to comprehensively evaluate the
complexity of the cardiac defect. However, in our study of
325 patients, only 22 patients (7%) were in the unclassified
category of RACHS-1 level. Most of these patients (n¼ 15)
underwent surgery without CPB use and did not developThe Journal of Thoracic and Caany postoperative complications. Fifth, we were not able
to determine which specific complication was associated
with worse outcomes. Sixth, the correlation of complica-
tions to an untoward outcome in the ‘‘failure to rescue’’
principle might not extrapolate to all institutions.5 Identi-
fying and correcting complications early might change the
relationship of complication development and mortality;
thus, the downstream effects of a given complication might
differ from 1 institution to the next, depending on the infra-
structure. The associations between complications and
outcome might be most important in establishing patterns
to target early recognition and preventive treatment. Finally,
given the retrospective nature of our analysis, the correla-
tion between postoperative complications and other
measured outcomes could not prove causality.
Despite these limitations, our study has shown that post-
operative cardiac and extracardiac complications affect a
large proportion of patients, and the consequences are
important to the length of the hospital course, cost, and
outcome. The greater rate of complications may allow for
better discrimination of outcomes among hospitals. A sys-
tematic and accurate analysis of complications could
inform strategies better than the currently used standard
criteria of mortality, mechanical ventilation duration, and
length of hospital stay. Postoperative cardiac and extracar-
diac complications will occur with pediatric cardiac sur-
gery, regardless of the use of CPB. We have reported a
significant association of postoperative complications
with currently measured outcomes, including mechanical
ventilation duration, length of intensive care unit stay,
length of hospital stay, and mortality. The association of
postoperative complications with reduced survival can
persist beyond hospital discharge. Additional studies are
needed to evaluate cardiac and extracardiac postoperative
complications as a valid measure of outcomes comparable
among pediatric heart programs.
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APPENDIX TABLE E1. Definitions of multiorgan complications
Complication Definition
Cardiac
Cardiac arrest Cessation of effective cardiac mechanical function necessitating cardiopulmonary resuscitation
Extracorporeal life support (ECMO)
in postoperative period
Need for ECMO coming off CPB or need for ECMO during operative period, including need for ECMO as
part of cardiopulmonary resuscitation
Reoperation Unplanned cardiac operation during same admission
Low cardiac output Low cardiac output state, characterized by use of 3 inotropes and associated with the following:
tachycardia, oliguria, decreased skin perfusion, metabolic acidosis, or vasopressin requirement for
hypotension and/or shock in postoperative period
Use of pacemaker, permanent Persistent rhythm problem necessitating placement of permanent pacemaker
Noncardiac
Neurologic
Seizures or focal neurologic deficit New-onset seizures or new-onset focal neurologic changes
Abnormal neuroimaging findings Head ultrasound/brain CT scan/brain MRI showing evidence of ischemic or hemorrhagic
changes—suspected to be of recent onset
Respiratory
Use of inhaled nitric oxide Indirect evidence of pulmonary hypertension (clinically significant elevation of pulmonary arterial
pressure requiring intervention)
Paralyzed diaphragm (requiring
surgical intervention)
Evidence of weak, immobile, or paradoxical movement assessed by ultrasound or fluoroscopy
Gastrointestinal
Necrotizing enterocolitis Suspected: feeding intolerance with abdominal distension, dilated bowel loops on radiograph and
hematochezia; diagnosed: persistent dilated loops on radiograph (fixed bowel loop pattern) and/or
perforation, along with feeding intolerance, abdominal distension, and hematochezia
Liver dysfunction Elevation of hepatic enzymes (ALT and AST 100 U/L)
Renal complications
Acute renal dysfunction Transient azotemia: elevated BUN and creatinine>1.5 times upper limit of normal for age (or twice the
most recent values)
Renal replacement therapy Acute renal failure with new requirement for temporary dialysis, including peritoneal dialysis or
hemodialysis or CVVH
Peritoneal drain catheter placement
(ascites, requiring drainage)
Accumulation of fluid in peritoneal cavity requiring peritoneal drain placement
Infectious
Pneumonia Fever, elevated WBC count, new infiltrate on chest radiograph, and positive endotracheal tube culture;
ventilator-associated pneumonia included
Sternal wound infection Including both superficial and deep sternal wound infections—superficial: purulent discharge from
superficial portion of incision; organisms isolated from aseptically obtained culture of fluid or tissue
from superficial portion of incision; tenderness and/or redness; deep: purulent drainage from deep
portions of incision; deep incision spontaneously dehisces or deliberately opened by surgeon; symptoms
of fever, localized tenderness, abscess, or other evidence of infection involving deep incision found on
direct examination
Suspected infection/bacteremia Clinical manifestations of infection (fever/elevated WBC count and/or elevated CRP) and no apparent
source of infection (culture negative)
Endocrine
Hyperglycemia Random blood glucose level>200 mg/dL necessitating insulin infusion
Adrenal insufficiency Abnormal basal cortisol and ACTH stimulation test necessitating use of stress dose steroids (including
both absolute and relative adrenal insufficiency)
Hematologic
Bleeding Postoperative or postprocedural bleeding requiring reoperation
ECMO, Extracorporeal membrane oxygenation; CPB, cardiopulmonary bypass; CT, computed tomography;MRI, magnetic resonance imaging; ALT, alanine aminotransferase;
AST, aspartate aminotransferase; BUN, blood urea nitrogen; CVVH, continuous venovenous hemofiltration; WBC, white blood cell; CRP, C-reactive protein; ACTH, adrenocor-
ticotropic hormone. Data from [No authors listed]. Part IV—dictionary of definitions of complications associated with treatment of patients with congenital cardiac disease.
Cardiol Young. 2008;18(Suppl S2):282-530 and from Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am.
1986;33:179-201.
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